SEC Form 4 · accession 0001209191-15-070216
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Sep 8, 2015
Accepted (ET)
Sep 10, 2015 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2015 | M | 2,500 | $2.35 | A | 109,061 | D | |
| Common StockF1 | Sep 8, 2015 | S | 2,500 | $26.00 | D | 106,561 | D | |
| Common Stock | Sep 8, 2015 | M | 690 | $2.90 | A | 107,251 | D | |
| Common Stock | Sep 10, 2015 | M | 5,000 | $2.35 | A | 112,251 | D | |
| Common StockF1 | Sep 10, 2015 | S | 5,000 | $28.00 | D | 107,251 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.35 | Sep 8, 2015 | M | 2,500 | D | — | Mar 12, 2018 | Common Stock | 2,500 | 3,000 | D |
| Stock Option (Right to Buy)F2 | $2.90 | Sep 8, 2015 | M | 430 | D | — | Jun 24, 2020 | Common Stock | 430 | 0 | D |
| Stock Option (Right to Buy)F2 | $2.90 | Sep 8, 2015 | M | 260 | D | — | Jun 24, 2020 | Common Stock | 260 | 3,740 | D |
| Stock Option (Right to Buy)F2 | $2.35 | Sep 10, 2015 | M | 3,000 | D | — | Mar 12, 2018 | Common Stock | 3,000 | 0 | D |
| Stock Option (Right to Buy)F2 | $2.35 | Sep 10, 2015 | M | 2,000 | D | — | Mar 12, 2018 | Common Stock | 2,000 | 30,000 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2Fully vested.